Evaluation of Glycated Hemoglobin (HbA1c) in Acute Coronary Syndrome (ACS)

Main Article Content

Konsam Photan Singh
L. Shaini
Th. Sachin Deba Singh
Victoria Kshetrimayum
Saishaym Sadanandam
Wahengbam Diana

Abstract

Aim: The aim of our study was to estimate the level of HbA1c in patients with Acute Coronary Syndrome (ACS). To determine any correlation between HbA1c, admission blood glucose (Random blood sugar), serum lipid profile among the cases and to evaluate the outcome during hospitalization.

Study Design and Setting: Cohort study.

Place and Duration of the Study: Department of Biochemistry and General Medicine including ICCU and Cardiology unit, RIMS, Imphal, between September 2015 to August 2017.

Methodology: Data were collected from 98 patients admitted in Medicine ward who were diagnosed with ACS irrespective of their diabetes status and they were divided into three groups according to their HbA1c levels (<5.7%, 5.7-6.4%, > 6.5%). The blood samples collected by venipuncture were analyzed for HbA1c level, done by RANDOX HbA1c Rx series (latex agglutination inhibition assay), admission blood glucose (measured by Trinder’s method) and serum lipid profile (RANDOX enzymatic Endpoint Method Rx series). The data were analyzed using statistical tools like Chi Square test, Independent sample t test, Pearson’s Correlation, Fisher’s exact test through SPSS 21.0.

Results: Majority of the patients were men (72.4%) & (27.6%) women and in the age group of 51-65 years. The mean age is 62.14 years. 54.1% of the ACS patients were already diagnosed cases of type 2 diabetes mellitus whereas 45.9% were non-diabetic. Out of 98 patients, 60 had HbA1c level in the diabetic range (≥6.5%), 25 in the pre-diabetic range (5.7-6.4%) and the remaining 13 were within normal range (<5.7%). Admission blood glucose, total cholesterol and LDL were positively correlated with HbA1c value.

Conclusion: The mortality of the ACS patients irrespective of diabetic status during hospitalization was associated with HbA1c value irrespective of diabetic status during hospitalization. However, it was not associated with thirty days mortality.

Keywords:
Glycated Hemoglobin (HbA1c), Acute Coronary Syndrome (ACS), blood glucose, serum lipid profile

Article Details

How to Cite
Singh, K., Shaini, L., Singh, T. S., Kshetrimayum, V., Sadanandam, S., & Diana, W. (2019). Evaluation of Glycated Hemoglobin (HbA1c) in Acute Coronary Syndrome (ACS). International Journal of Biochemistry Research & Review, 27(1), 1-9. https://doi.org/10.9734/ijbcrr/2019/v27i130110
Section
Original Research Article

References

Uçucu M, Alibaz Öner F, Yurdakul S, Ergüney M. In-hospital mortality in patients with impaired fasting glucose and acute coronary syndromes. Marmara Med J. 2010;23(2):257-62.

Prabhakaran D, Panniyammakal Jeemon, Ambuj Roy. Cardiovascular diseases in India: Current epidemiology and future directions. American Heart Association, Journal of the American College of Cardiology. 2016;73(1):79-95.

Panduranga P, Sulaiman KJ, Al-Zakwani IS, Al-Lawati JA. Characteristics, management and in-hospital outcomes of diabetic acute coronary syndrome patients in Oman. Saudi Med J. 2010; 31(5):520-4.

Norhammar A, Tenerz A, Nilsson G, Hamsten A, Efendíc S, Rydén L, et al. Glucose metabolism in patients with acute myocardial infarction and no previous diagnosis of diabetes mellitus: A prospective study. Lancet 2002;359(9324): 2140-4.

Hadjadj S, Coisne D, Mauco G, Ragot S, Duengler F, Sosner P, et al. Prognostic value of admission plasma glucose and HbA1c in acute myocardial infarction. Diabet Med. 2004;21(4):305-10.

ADA workshop report; International expert committee report on the role of the A1c assay in the diagnosis of diabetes. Diabetes Care. 2009;32(7):1327-34.

Buse JB, Ginsberg HN, Bakris GL, Clark NG, Costa F, Eckel R et al. Primary prevention of cardiovascular diseases in people with diabetes mellitus: Scientific statement from the American heart association and the American diabetes association. Diabetes Care. 2007;30(1): 162-72.

Kaneto H, Katakami N, Matsuhisa M, Matsuoka TA. Role of reactive oxygen species in the progression of type 2 diabetes and atherosclerosis. Mediators Inflamm (453892); 2010.
Available:http://dx.doi.org/10.1155/2010/453892
[Accessed on October 5,2017]

Yadav AS, Bhagwat VR. Lipid profile pattern in anginal syndrome patients from Marathwada region of Maharashtra. Maharastra State Journal of Medical Education & Research. 2012;2(2):12-15.

Stary HC, Blankenhorn DH, Chandler AB, Glagov S, Insull W Jr, Richardson M, et al. A definition of the in tima of human arteries and of its atherosclerosis prone regions: A report from the committee on vascular lesions of the council on arteriosclerosis, American Heart Association. Circulation. 1992;85(1):391-405.

Stary HC, Chandler AB, Glagov S, Guyton JR, Insull W Jr, Rosenfeld ME et al. A definition of initial, fatty streak, and intermediate lesions of atherosclerosis: A report from the committee on vascular lesions of the council on Arteriosclerosis, American Heart Association. Arterioscler Thromb. 1994;14(5):840-56.

Stary HC, Chandler AB, Glagov S, Guyton JR, Insull W Jr, Rosenfeld ME et al. A definition of advanced types of athero-sclerotic lesions and histological classification of atherosclerosis: A report from the committee on vascular lesions of the council on arteriosclerosis, American heart association. Circulation 1995;15(9): 1512-31.

American Diabetes Association. Clinical Diabetes: Standards of medical care in diabetes. 2016;34(1):3-21.

Turner RC, Millns H, Neil HA, Stratton IM, Manley SE, Matthews DR, et al. Risk factors for coronary artery disease in non-insulin dependent diabetes mellitus: United Kingdom Prospective Diabetes Study (UKPDS: 23). BMJ 1998;316(7134):823-8.

Saydah S, Tao M, Imperatore G, Gregg E. GHb level and subsequent mortality among adults in the U.S. Diabetes Care. 2009; 32(8):1440-6.

Naomi B, Craig S. Wright, Travier N, Cunningham CW, John Hornell, Pearce N, et al. A New Zealand linkage study examining the associations between A1C concentration and mortality. Diabetic Care. 2008;31(6):1144-9.

Homoud MK. Coronary artery disease [Dissertation]. Tufts-New England medical centre: Spring; 2008.

Ranjith N, Pegoraro RJ, Zaahl MG. Risk factors associated with acute coronary syndromes in South African Asian Indian patients [The AIR Study]. J Clinic Experiment Cardiol. 2011;10(2):1-5.

Freidewald WF, Levy RI, Fredickson DS. Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. Clin Chem. 1972;18(6): 499-502.

Gupta R, Gupta VP, Sarna M, Prakash H, Rastogi S, Gupta KD. Serial epidemiological surveys in an urban Indian population demonstrate increasing coronary risk factor among the lower socioeconomic strata. J Assoc Physicians India. 2003;55(1):470-7.

Jain S, Chauhan VS, Nayak R. Glycoslated haemoglobin as a diagnostic marker of diabetes mellitus in acute myocardial infarction and association with obesity. Int Res J Med Sci. 2015;3(3):7- 10.

Yathish TR, Manjula CG, Srinivas RD, Gayathree L. A study on the association of coronary artery disease and smoking by a questionnaire method. JCDR. 2011;5: 264-8.

Morrow JD, Frei B, Longmire AW, Gaziano JM, Lynch SM, Shyr Y, et al. Increase in circulating products of lipid peroxidation (F2-isoprostanes) in smokers: Smoking as a cause of oxidative damage. N Engl J Med. 1995;332(18):1198-203.

Olga M, Gulnora N, Refat M. The prevalence of hypertension in patients with ACS/AMI (according to the register of acute coronary syndrome/acute myocardial infarction in Uzbekistan “RACSMI-UZ’’). J of Hypertension. 2016; 34(S1):357-8.

Rakugi H, Yu H, Kamitani A, Nakamura Y, Ohishi M, Kamide K, et al. Links between hypertension and myocardial infarction. American Heart Journal. 1996;132(1 Pt 2): 213–21.

Manal KAR, Rasheed JI, Mohmmad HS. The value of admission glucose and glycosylated haemoglobin in patients with acute coronary syndrome. The Iraqi postgraduate Med J. 2013;12(1):75-84.